Evaluation of the Effect of Lumbar Belt on Spinal Mobility in Subjects With and Without Low Back Pain (LombaMob)

April 21, 2023 updated by: Thuasne

Low back pain (LBP) is a common condition worldwide as the lifetime prevalence is up to 80%. It is defined as pain in the lumbosacral region in which the etiological causes are most often mechanical, and it is therefore defined as "non-specific LBP".

Lumbar belts are used in the treatment and secondary prevention of LBP. They are supposed to reduce the intensity of pain by improving the functional capacities of daily activities and thus preventing the risk of chronicity related to immobility (HAS).

Despite some proof of their efficiency in the literature, it is still not clear how the pressure applied by the belt and the immobilization constraints on the trunk improve the patient mobility.

Considering that LBP causes movement limitation, and that the lumbar belt contributes to initially decrease the pain intensity, as well as to improve the mobility and the functional capacities of the patient, we propose to evaluate the clinical and biomechanical effects of the lumbar belt during different trunk movements in subjects with and without LBP.

This is a clinical investigation on a CE marked medical device, used in accordance with its intended purpose, in the context of a post-marketing clinical follow-up with additional non-invasive procedures (IC SCAC: case 4.1 of the medical device regulation 2017/745).This is a prospective, monocentric, comparative and open clinical investigation.

The objective is to evaluate the clinical and functional effects related to spinal movements in 2 conditions, with and without the wearing of a lumbar belt. The study will be carried out with two groups of subjects: one group of subjects presenting an episode of LBP (NS>4) (subjects considered to have subacute or chronic nonspecific LBP according to the classification of LBP) and another group of control subjects with no spinal symptoms and no pain that could limit movement (healthy subjects).

Each group will undergo 2 visits on 2 separate days with a 30-day delay for the LBP subjects and a 7-day delay for the healthy subjects

  • a first visit (V1) for inclusion, familiarization with a clinical and functional test, and an external measurement of spinal mobility during movements;
  • a second visit (V2) for a clinical and functional evaluation, external measurements of spinal mobility and biomechanical measurements.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Saint-Étienne, France
        • Recruiting
        • CHU de St Etienne
        • Contact:
          • Paul Calmels, MD, PUPH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria for subjects Low Back Pain:

  • Male or female,
  • Aged between 18 and 70 years,
  • With a waist circumference between 75 cm and 110 cm,
  • With a 18.5 < BMI < 30 kg/m2,
  • Suffering from a current episode of non-specific low back pain (symptomatic subjects),
  • At least one average low back pain at rest or during exercise in the last 72 hours collected at inclusion (≥ 4/10 on an EN scale),
  • Followed by a primary care physician or specialist for this clinical condition,
  • Having received or scheduled to receive an EOS type radiological workup in less than 6 months
  • Affiliated or entitled to a social security system,
  • Having signed the written consent.

Inclusion Criteria for healthy subjects:

  • Male or female,
  • Aged 18 to 70 years,
  • With a waist circumference between 75 cm and 110 cm,
  • With a 18.5 < BMI < 30 kg/m2,
  • Never having suffered from LBP or any other type of lumbar disorder,
  • Affiliated or entitled to a social security system,
  • Having signed the written consent.

Exclusion Criteria:

  • Subjects suffering from LBP of inflammatory, tumoral or infectious cause.
  • Pregnant women.
  • Subjects with cognitive or mental disorders or confirmed depression;
  • Subjects who received an infiltration less than one month prior to the inclusion visit or planned during the study;
  • Subjects with a known allergy to any of the materials;
  • Subjects complaining of chronic, unstabilized or symptomatic cardiac or respiratory problems;
  • Subjects with current participation in an interventional investigational drug or device therapy study that impacts the endpoints.
  • Subjects under legal protection or unable to express their consent;
  • Subject presenting a lumbar radicular syndrome (hiatal hernia, spinal stenosis...).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: Lumbar belt Lombastab® (Thuasne, Levallois Perret, France)
Low back pain patients wear Lumbar belt Lombastab® during 4 weeks according to the instructions given by the investigator of the study.

All subjects (LBP group and healthy group) wear the belt during the two visits to perform differents tests.

The invistigator will ask the LBP patients to wear the lumbar belt between the two visits (for 4 weeks, for 4 to 8 hours per day)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal Mobility assessed by the fingertip to floor distance test (FTF)
Time Frame: Immediately with and without wearing the lumbar belt (Day 0)
The effect of wearing a lumbar belt on spinal mobility during anterior flexion of the trunk (sagittal plane) in subjects with LBP using the fingertip to floor (FTF) distance test.
Immediately with and without wearing the lumbar belt (Day 0)
Spinal Mobility assessed by the fingertip to floor distance test (FTF)
Time Frame: After 4 weeks with and without wearing the lumbar belt (Day 30)
The effect of wearing a lumbar belt (for 4 weeks) on spinal mobility during anterior flexion of the trunk (sagittal plane) in subjects with LBP using the fingertip to floor (FTF) distance test.
After 4 weeks with and without wearing the lumbar belt (Day 30)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal Mobility assessed by the fingertip to floor distance test (FTF)
Time Frame: During the Day 0 (for both groups) and Day 30 (for LBP patients) with and without wearing the belt

Spinal mobility (using the FTF test in forward flexion, the FTF test in lateral flexion and the sternum to wall test in extension):

a.1) In subjects with LBP at Day 0 and Day 30

a.2) In healthy subjects (at Day 0)

a.3) Between healthy subjects and LBP subjects (at Day 0)

During the Day 0 (for both groups) and Day 30 (for LBP patients) with and without wearing the belt
Pain level assessed by Numerical Scale (NS)
Time Frame: During the Day 0 and Day 30 immediately before and after wearing the belt, and after each movement with and without the belt (for LBP patients)
Pain in LBP subjects (Day 0 vs Day 30) using Numerical Scale (NS) from 0 to 10 (0: no pain and 10: worst pain)
During the Day 0 and Day 30 immediately before and after wearing the belt, and after each movement with and without the belt (for LBP patients)
Functional capacities assessed by Oswestry Disability Index (ODI)
Time Frame: During the beginning of Day 0 and Day 30 (for LBP patients)
Functional capacities of LBP subjects (Day 0 and Day 30) using Oswestry Disability Index (ODI)
During the beginning of Day 0 and Day 30 (for LBP patients)
Kinematics of the spinal segments assessed by Inertial Measurement Units sensors
Time Frame: During Day 0 (for both groups) and Day 30 (for LBP patients) with and without wearing the belt

Kinematics of the spinal segments using 3 IMUs (Inertial Measurement Units) sensors:

d.1) In LBP subjects (Day 0 vs Day 30) d.2) In healthy subjects (at Day 0) d.3) Between healthy subjects and LBP subjects (at Day 0)

During Day 0 (for both groups) and Day 30 (for LBP patients) with and without wearing the belt
Trunk posture measured by 8-camera image stereo correlation system
Time Frame: During Day 7 (for healthy subjects) and Day 30 (for LBP patients)
Trunk posture using 8-camera image stereo-correlation system (Alternative to motion capture) e.1) In subjects with LBP (Day 30) e.2) In healthy subjects (at Day 7) e.3) Between healthy subjects and subjects with LBP (Day 7 vs Day 30)
During Day 7 (for healthy subjects) and Day 30 (for LBP patients)
The pressure applied by the belt on the trunk assessed by piezo-resistive sensors
Time Frame: During Day 7 (for healthy subjects) and Day 30 (for LBP patients)
The pressure applied by the belt on the trunk using piezo-resistive sensors f.1) In subjects with LBP (Day 30) f.2) In healthy subjects (at Day 7) f.3) Between healthy subjects and LBP subjects (Day 7 vs Day 30)
During Day 7 (for healthy subjects) and Day 30 (for LBP patients)
Deformation of the lumbar belt assessed by 8-camera image stereo-correlation system
Time Frame: During Day 7 (for healthy subjects) and Day 30 (for LBP patients)

To evaluate, during spinal movements, the deformation of the lumbar belt considered as a mechanism of action using 8-camera image stereo-correlation system:

g.1) In LBP subjects (Day 30) g.2) In healthy subjects (Day 7) g.3) Between healthy subjects and LBP subjects (Day 7 vs Day 30)

During Day 7 (for healthy subjects) and Day 30 (for LBP patients)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2022

Primary Completion (Anticipated)

August 31, 2023

Study Completion (Anticipated)

August 31, 2023

Study Registration Dates

First Submitted

October 21, 2022

First Submitted That Met QC Criteria

October 26, 2022

First Posted (Actual)

October 31, 2022

Study Record Updates

Last Update Posted (Actual)

April 24, 2023

Last Update Submitted That Met QC Criteria

April 21, 2023

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-A01060-43
  • ANSM (Other Identifier: 2023-A01346-39)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Lumbar belt

3
Subscribe